| Ms Melissa L Matherson, MFT | |
|
2789 Ortiz Ave, Fort Myers, FL 33905-7806 | |
| (239) 791-1586 | |
| Not Available |
| Full Name | Ms Melissa L Matherson |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 2789 Ortiz Ave, Fort Myers, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043334675 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | MFC46668 (California) | Secondary |
| 106H00000X | Marriage & Family Therapist | MT2697 (Florida) | Primary |
| Entity Name | Personal Recovery Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881990869 PECOS PAC ID: 5092611384 Enrollment ID: O20200416000590 |
News Archive
Clinical researchers from Cornell Weil Medical School and University of Chicago Medical School will present research conducted on Raman Molecular Imaging's ability to differentiate diagnostic dilemmas in lung and kidney tumors at the United States and Canadian Academy of Pathology's 100th Annual Meeting, Feb. 26-March 4 at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
The nation's fourth leading cause of death, chronic obstructive pulmonary disease (COPD), is now being measured by the Minnesota Department of Health's Environmental Public Health Tracking Program. The program focuses on three major causes of hospitalizations in Minnesota that can be triggered or made worse by environmental factors such as secondhand smoke or outdoor air pollution — asthma, heart attacks and COPD.
CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.
The emergence of this variant highlighted the uneven pace of mutation and selection of variants. New bioinformatics tools are the need of the hour to clarify this and confirm a dynamic evolution by tracking the mutation rates of the spike protein. It generally takes 1 – 6 months for current variants causing COVID-19 case peaks and deaths to survive the pressure of selection.
A new study from the University of Gothenburg, Sweden, shows how analysing spinal fluid can help to detect Alzheimer's disease at an early stage. The researchers behind the study hope that their findings will contribute to a greater international breakthrough for this type of diagnostic method.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Melissa L Matherson, MFT 3763 Evans Ave, Fort Myers, FL 33901-9302 Ph: (239) 931-9035 | Ms Melissa L Matherson, MFT 2789 Ortiz Ave, Fort Myers, FL 33905-7806 Ph: (239) 791-1586 |
News Archive
Clinical researchers from Cornell Weil Medical School and University of Chicago Medical School will present research conducted on Raman Molecular Imaging's ability to differentiate diagnostic dilemmas in lung and kidney tumors at the United States and Canadian Academy of Pathology's 100th Annual Meeting, Feb. 26-March 4 at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
The nation's fourth leading cause of death, chronic obstructive pulmonary disease (COPD), is now being measured by the Minnesota Department of Health's Environmental Public Health Tracking Program. The program focuses on three major causes of hospitalizations in Minnesota that can be triggered or made worse by environmental factors such as secondhand smoke or outdoor air pollution — asthma, heart attacks and COPD.
CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.
The emergence of this variant highlighted the uneven pace of mutation and selection of variants. New bioinformatics tools are the need of the hour to clarify this and confirm a dynamic evolution by tracking the mutation rates of the spike protein. It generally takes 1 – 6 months for current variants causing COVID-19 case peaks and deaths to survive the pressure of selection.
A new study from the University of Gothenburg, Sweden, shows how analysing spinal fluid can help to detect Alzheimer's disease at an early stage. The researchers behind the study hope that their findings will contribute to a greater international breakthrough for this type of diagnostic method.
› Verified 9 days ago
Ms. Elaine Marie Rigby, M.S., L.M.F.T. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3900 Broadway Ste B1, Fort Myers, FL 33901 Phone: 239-939-2808 | |
Hanna Pratico, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 18362 Ostego Dr, Fort Myers, FL 33967 Phone: 239-287-3551 | |
Kaleesha Bent, M.S. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 15901 Bass Rd Ste 108, Fort Myers, FL 33908 Phone: 239-343-6050 Fax: 239-343-6051 | |
Alyssa Biestek, MS Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2734 Oak Ridge Ct, Fort Myers, FL 33901 Phone: 239-963-4367 | |
Kerrie L. Budagher, MSW, ISW Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2180 W 1st St, Fort Myers, FL 33901 Phone: 505-228-4959 | |
Anisa Siddiqkara, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2180 Maravilla Ln, Fort Myers, FL 33901 Phone: 239-332-8009 |